SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ipca Laboratories plans Indonesian acquisition

29 Sep 2011 Evaluate
Ipca Laboratories Ltd plans to acquire a pharmaceutical company in Indonesia with a view to enter the largest South-East Asian market.The company has put together a $ 20 million war chest for the acquisition, to be made within the next few months, and a number of companies have been short listed. The company needs good access to the Indonesian market and an established pharmaceutical company would be good vehicle to market Indian pharma products in Indonesia.

Ipca Laboratories Share Price

1557.90 -5.80 (-0.37%)
07-May-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1831.30
Dr. Reddys Lab 1307.00
Cipla 1361.00
Zydus Lifesciences 940.10
Lupin 2460.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×